Sayre Therapeutics Private Limited

Sayre Therapeutics Private Limited - healthcare in Somasundara Palya, Karnataka, India. FY 2026 financials & compliance.
CIN U85110KA2015PTC079687 Incorporated 07 April 2015 ROC Bangalore HQ Somasundara Palya, Karnataka, India
Active Private Limited Company healthcare MSME · Small
Data last updated
Revenue · FY 2026
₹25.34 Cr
▲ 7% YoY
Net profit · FY 2026
₹12.09 Lakh
Net margin 0.5%
EBITDA · FY 2026
₹1.46 Cr
EBITDA margin 5.8%
Authorised capital
₹30.3 Lakh
Registered with MCA
Paid-up capital
₹28.79 Lakh
Issued & subscribed
Open charges
₹36.5 Cr
Satisfied ₹18.3 Cr
Company age
11 yrs
Est. 2015
Employees · EPFO
24
Provident fund records

About Sayre Therapeutics Private Limited

Data last updated:

Sayre Therapeutics Private Limited is a private limited company based in Somasundara Palya, Karnataka, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 07 April 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U85110KA2015PTC079687. Its GSTIN is 29AAVCS6145A1Z1 (Karnataka).

The company has an authorised share capital of ₹30.3 Lakh and a paid-up capital of ₹28.79 Lakh. It is led by directors including Shukrit Sudhir Chimote and Mahendran Balachandran.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Flat No.1104 Sobha Cinnamon Apartment Haralur Road, Somasundara Palya, Karnataka, India – 560102.

As per the financials filed for FY 2026, the company reported a revenue of ₹25.34 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹12.09 Lakh (net margin 0.5%) and EBITDA of ₹1.46 Cr (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 22% over five years.

The company has about 24 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Sayre Therapeutics. As per MCA filings, the company has open charges of ₹36.5 Cr and satisfied charges of ₹18.3 Cr on record. The company has 6 deals on record (3 funding rounds, 2 secondary share transfers, 1 debt financing), with disclosed funding of ₹63.1 Cr; the latest was in December 2021.

Sayre Therapeutics Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0042181). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sayretherapeutics.com.

Company details

CIN U85110KA2015PTC079687
Registration Number 079687
Incorporation Date 07 April 2015
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KR-03-0042181
Key People
Shukrit Sudhir Chimote Director Mahendran Balachandran Director Sasidharan Rajesh Director

Recognitions & Rankings of Sayre Therapeutics

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-KR-03-0042181

Contact details

Sayre Therapeutics Private Limited's registered office is in Somasundara Palya, Karnataka. Its website is sayretherapeutics.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    sayretherapeutics.com
  • Social Media
  • Registered Address
    Flat No.1104 Sobha Cinnamon Apartment Haralur Road, Somasundara Palya, Karnataka, India – 560102
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs

To see the full contact details of Sayre Therapeutics Private Limited, buy the company report.

Comprehensive company report
Sayre Therapeutics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Sayre Therapeutics operates one associated brand: Sayre Therapeutics. Each brand links to its own profile.

BrandDescriptionWebsite
Sayre Therapeutics
Access to therapies for rare and life-threatening diseases is provided.sayretherapeutics.com

Business activity

The main business activity of Sayre Therapeutics is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Sayre Therapeutics Private Limited, buy the company report.

Financials of Sayre Therapeutics Private Limited

FY 2026 filings available

Sayre Therapeutics Private Limited reported revenue of ₹25.34 Cr (up 7% YoY) for FY 2026.

Revenue · FY 2026
₹25.34 Cr ▲ 7%
Net profit · FY 2026
₹12.09 Lakh margin 0.5%
EBITDA · FY 2026
₹1.46 Cr margin 5.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 12%
5 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▼ 1%
3 years · compounded
▲ 34%
5 years · compounded
▲ 21%

Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 7% growth in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹25.34 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.46 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹12.09 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin5.8%
Net Profit Margin0.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sayre Therapeutics Private Limited, buy the company report.

Board of directors of Sayre Therapeutics Private Limited

Sayre Therapeutics has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Shukrit Sudhir ChimoteDirector07 Apr 201511 Years 7 MonthsCurrent
Mahendran Balachandran
Also directs: Erasmic Investment Advisors LLP, Accel Partners India LLP, Accel India Advisors LLP and 5 more
Director30 Jun 201511 Years 4 MonthsCurrent
Sasidharan RajeshDirector23 Dec 20214 Years 10 MonthsCurrent
View all directors

Auditor

Sayre Therapeutics Private Limited is audited by MDA & Co for the financial year 2026.

Auditor firmFinancial yearFirm registration number
MDA & CoFY 2026012023S

Shareholding

The shareholding of Sayre Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2026FY 2025FY 2024FY 2023FY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Sayre Therapeutics Private Limited, buy the company report.

Charges & borrowings

Open charges
₹36.5 Cr
Satisfied charges
₹18.3 Cr
Breakdown by lending institutions
Axis Bank Limited₹18.00 Cr
Others₹10.00 Cr
Hdfc Bank Limited₹8.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
12 Oct 2023100808839Axis Bank Limited₹18 CrOpen
29 Nov 2021100516460Hdfc Bank Limited₹8.5 CrOpen
26 Jul 2021100481213Others₹10 CrOpen
29 Apr 2019100262942Hdfc Bank Limited₹6.3 CrSatisfied
27 Dec 2017100151736Hdfc Bank Limited₹5 CrSatisfied

To see the full charge records of Sayre Therapeutics Private Limited, buy the company report.

Total charge records: 6 View all charges

Deals & funding

Sayre Therapeutics Private Limited has 6 deals on record (3 funding rounds, 2 secondary share transfers, 1 debt financing), with disclosed funding of ₹63.1 Cr; the latest was in December 2021.

Total deals
6
Funding rounds
3
Secondary share transfers
2
Debt financing
1
Disclosed funding
₹63.1 Cr

Deals on record (4 of 6)

WhenDealAmountParties
Mar 2019Secondary share transferUndisclosedSeller: an individual
Mar 2019Secondary share transferUndisclosedBuyer: Sayre Esop Trust
Seller: an individual
Mar 2017Debt financing₹7 CrInvestors: InnoVen Capital
Jun 2015Funding round · Series A₹24.8 CrInvestors: Accel India, Aarin Capital

To see the full deal history of Sayre Therapeutics Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sayre Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Sayre Therapeutics Private Limited has a workforce of 24 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
24
Active EPFO establishments
1
Employee growth
4.3%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2724
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Sayre Therapeutics Private Limited, buy the company report.

GST

Sayre Therapeutics has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
29AAVCS6145A1Z1KarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Sayre Therapeutics Private Limited, buy the company report.

Recent activity

Sayre Therapeutics Private Limited has 8 board changes on record since 2015: 3 appointments and 5 cessations. The latest: Sasidharan Rajesh ceased to be Additional Director on 30 Sep 2022.

Filing
Sayre Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Bangalore.
AGM
Sayre Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Axis Bank Limited amounted to Rs. 1,800.00 Lakh with Charge ID 100808839 was registered on 12 Oct 2023.
Ceased
Sasidharan Rajesh ceased to be Additional Director.
Ceased
Praveenbose Sivasankaran ceased to be Director.
Appointed
Sasidharan Rajesh was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 850.00 Lakh with Charge ID 100516460 was registered on 29 Nov 2021.
Charges
A charge registered on 29 Apr 2019 via Charge ID 100262942 with Hdfc Bank Limited was fully satisfied on 01 Sep 2021.
Charges
A charge registered on 27 Dec 2017 via Charge ID 100151736 with Hdfc Bank Limited was fully satisfied on 01 Sep 2021.
Charges
A charge with Others amounted to Rs. 1,000.00 Lakh with Charge ID 100481213 was registered on 26 Jul 2021.
Charges
A charge registered on 21 Mar 2017 via Charge ID 100093897 with Others was fully satisfied on 20 Jan 2020.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 630.00 Lakh with Charge ID 100262942 was registered on 29 Apr 2019.

8 earlier events are in the company report.

News

Frequently asked questions

Sayre Therapeutics is an active private limited company based in Somasundara Palya, Karnataka, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 07 April 2015 (11+ years old) and is registered under CIN U85110KA2015PTC079687.

Sayre Therapeutics has 3 current directors:

The latest financial statements of Sayre Therapeutics on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.

The GSTIN of Sayre Therapeutics is 29AAVCS6145A1Z1, registered in Karnataka.

The CIN (Corporate Identification Number) of Sayre Therapeutics is U85110KA2015PTC079687. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sayre Therapeutics was incorporated on 07 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Bangalore.

Sayre Therapeutics has 6 deals on record (3 funding rounds, 2 secondary share transfers, 1 debt financing), with disclosed funding of ₹63.1 Cr; the latest was in December 2021.

Sasidharan Rajesh ceased to be Additional Director on 30 Sep 2022. Praveenbose Sivasankaran ceased to be Director on 23 Dec 2021. Sasidharan Rajesh was appointed as Director on 23 Dec 2021. Sayre Therapeutics has 8 board changes on record in total.

Yes, Sayre Therapeutics is registered as a small enterprise under Udyam registration (number: UDYAM-KR-03-0042181).

Sayre Therapeutics can be reached through the website sayretherapeutics.com. Its registered office is in Somasundara Palya, Karnataka, India.